Celaid Therapeutics raises ¥400 million Series B second close
Celaid Therapeutics Issuer · Shionogi & Co., Ltd. Investor · Teikoku Ventures Investor
Intelligence
The deal
- Type
- Funding
- Amount
- JPY 400M
- Structure
- Second close; cumulative funding to date about JPY 3.42 billion incl. grants
- Status
- Closed
- Round
- Series B second close
- Valuation
- Not recorded
- Region
- Japan
- Date
- 4 October 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Activity